About 9 results found for searched term "54-47-7" (0.038 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M3617 | LY2874455 | FGFR |
| LY2874455 is a novel and potent FGF/FGFR inhibitor. | ||
| M9242 | ISRIB | PERK |
| ISRIB is a potent and selective PERK inhibitor with IC50 of 5 nM. | ||
| M9955 | LL-37 (Human) | Anti-infection |
| LL37 | ||
| Antibacterial Protein LL-37 (human) is a 37-residue, amphipathic, cathelicidin-derived antimicrobial peptide, which exhibits a broad spectrum of antimicrobial activity. | ||
| M17374 | 3,4-Dihydroxyallylbenzene 3,4-di-O-glucoside | Phenylpropanoids |
| 3,4-Dihydroxyallylbenzene 3,4-di-O-glucoside | ||
| M18516 | (-)-dihydrocarveol | Others |
| (-)-dihydrocarveol | ||
| M20917 | Pyridoxal phosphate | Vitamin |
| pyridoxal 5'-phosphate, PAL-P, PLP, Vitamin B6 phosphate | ||
| Pyridoxal phosphate, the active form of vitamin B6, acts as a coenzyme in all transamination reactions, and in certain decarboxylation, deamination, and racemization reactions of amino acids. | ||
| M28051 | Fezagepras sodium | GPR/FFAR |
| Setogepram sodium; PBI-4050 sodium | ||
| Fezagepras (Setogepram) sodium acts as an orally active agonist for GPR40 and as an antagonist or inverse agonist for GPR84. Fezagepras sodium decreases renal, liver and pancreatic fibrosis. Fezagepras sodium exerts anti-fibrotic, anti-inflammatory and anti-proliferative actions. | ||
| M30278 | JNJ-10181457 | Histamine Receptor |
| JNJ-10181457 is a selective non-imidazole histamine H3 receptor antagonist that normalizes acetylcholine neurotransmission. | ||
| M57561 | Adenosine-5'-13C | Others |
| Adenosine-5'-13C | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
